Christopher Fegan

10PUBLICATIONS
21CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Biologically active moleculesCell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 25, 2022
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma.

Thomas A Burley, Emma Kennedy, Georgia Broad

|Jun 14, 2021
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel).

Toby A Eyre, Gavin Preston, Huseini Kagdi

|Nov 09, 2019
Increased frequency of CD4<sup>+</sup> PD-1<sup>+</sup> HLA-DR<sup>+</sup> T cells is associated with disease progression in CLL.

Lauren Elston, Chris Fegan, Robert Hills

|Mar 13, 2019
Is venetoclax a new wonder drug in CLL?

Chris Fegan, Chris Pepper

|Feb 24, 2019
Telomere fusions associate with coding sequence and copy number alterations in CLL.

Laura Escudero, Kez Cleal, Kevin Ashelford

|Jul 17, 2018
Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline.

Anna H Schuh, Nilima Parry-Jones, Niamh Appleby

Pageof 2

Frequent Collaborators

3 joint publications

Chris Pepper

2 joint publications

Duncan M Baird

1 joint publications

Guy Pratt

1 joint publications

Laura Escudero